That means anyone microdosing is essentially running a personal science experiment on themselveswithout a roadmap
Semaglutide, marketed as Ozempic for diabetes and Wegovy for obesity, has emerged as the commercial powerhouse, with the oral version launching in January 2026 following December 2025 FDA approval [3]
It is also unclear whether patients would have to take these drugs for the rest of their lives or in combination with other procedures and therapies
The lyophilized powder might look fine
Advancements in GLP-1 Therapy: Specialized Peptide Solutions In the advancement of GLP-1 therapies, researchers employ fatty acid modification and Fc fusion protein techniques to enhance the effectiveness of GLP-1 receptor agonists
Whats most discouraging is that even though Ive been so strict with my diet, my weight hasnt changed at all, and my blood sugar was all over the place